Cargando…
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
Background. Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including Mycobacterium tuberculosis, achieve long-term persistence within host cells. The mechanisms underpinning this key intrace...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172425/ https://www.ncbi.nlm.nih.gov/pubmed/28008422 http://dx.doi.org/10.12688/wellcomeopenres.10036.2 |
_version_ | 1782484126755979264 |
---|---|
author | Fineran, Paul Lloyd-Evans, Emyr Lack, Nathan A. Platt, Nick Davis, Lianne C. Morgan, Anthony J. Höglinger, Doris Tatituri, Raju Venkata V. Clark, Simon Williams, Ian M. Tynan, Patricia Al Eisa, Nada Nazarova, Evgeniya Williams, Ann Galione, Antony Ory, Daniel S. Besra, Gurdyal S. Russell, David G. Brenner, Michael B. Sim, Edith Platt, Frances M. |
author_facet | Fineran, Paul Lloyd-Evans, Emyr Lack, Nathan A. Platt, Nick Davis, Lianne C. Morgan, Anthony J. Höglinger, Doris Tatituri, Raju Venkata V. Clark, Simon Williams, Ian M. Tynan, Patricia Al Eisa, Nada Nazarova, Evgeniya Williams, Ann Galione, Antony Ory, Daniel S. Besra, Gurdyal S. Russell, David G. Brenner, Michael B. Sim, Edith Platt, Frances M. |
author_sort | Fineran, Paul |
collection | PubMed |
description | Background. Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including Mycobacterium tuberculosis, achieve long-term persistence within host cells. The mechanisms underpinning this key intracellular pro-survival strategy remain incompletely understood. Host macrophages infected with intracellular mycobacteria share phenotypic similarities with cells taken from patients suffering from Niemann-Pick Disease Type C (NPC), a rare lysosomal storage disease in which endocytic trafficking defects and lipid accumulation within the lysosome lead to cell dysfunction and cell death. We investigated whether these shared phenotypes reflected an underlying mechanistic connection between mycobacterial intracellular persistence and the host cell pathway dysfunctional in NPC. Methods. The induction of NPC phenotypes in macrophages from wild-type mice or obtained from healthy human donors was assessed via infection with mycobacteria and subsequent measurement of lipid levels and intracellular calcium homeostasis. The effect of NPC therapeutics on intracellular mycobacterial load was also assessed. Results. Macrophages infected with intracellular mycobacteria phenocopied NPC cells, exhibiting accumulation of multiple lipid types, reduced lysosomal Ca (2+ )levels, and defects in intracellular trafficking. These NPC phenotypes could also be induced using only lipids/glycomycolates from the mycobacterial cell wall. These data suggest that intracellular mycobacteria inhibit the NPC pathway, likely via inhibition of the NPC1 protein, and subsequently induce altered acidic store Ca (2+) homeostasis. Reduced lysosomal calcium levels may provide a mechanistic explanation for the reduced levels of phagosome-lysosome fusion in mycobacterial infection. Treatments capable of correcting defects in NPC mutant cells via modulation of host cell calcium were of benefit in promoting clearance of mycobacteria from infected host cells. Conclusion. These findings provide a novel mechanistic explanation for mycobacterial intracellular persistence, and suggest that targeting interactions between the mycobacteria and host cell pathways may provide a novel avenue for development of anti-TB therapies. |
format | Online Article Text |
id | pubmed-5172425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-51724252016-12-20 Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway Fineran, Paul Lloyd-Evans, Emyr Lack, Nathan A. Platt, Nick Davis, Lianne C. Morgan, Anthony J. Höglinger, Doris Tatituri, Raju Venkata V. Clark, Simon Williams, Ian M. Tynan, Patricia Al Eisa, Nada Nazarova, Evgeniya Williams, Ann Galione, Antony Ory, Daniel S. Besra, Gurdyal S. Russell, David G. Brenner, Michael B. Sim, Edith Platt, Frances M. Wellcome Open Res Research Article Background. Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including Mycobacterium tuberculosis, achieve long-term persistence within host cells. The mechanisms underpinning this key intracellular pro-survival strategy remain incompletely understood. Host macrophages infected with intracellular mycobacteria share phenotypic similarities with cells taken from patients suffering from Niemann-Pick Disease Type C (NPC), a rare lysosomal storage disease in which endocytic trafficking defects and lipid accumulation within the lysosome lead to cell dysfunction and cell death. We investigated whether these shared phenotypes reflected an underlying mechanistic connection between mycobacterial intracellular persistence and the host cell pathway dysfunctional in NPC. Methods. The induction of NPC phenotypes in macrophages from wild-type mice or obtained from healthy human donors was assessed via infection with mycobacteria and subsequent measurement of lipid levels and intracellular calcium homeostasis. The effect of NPC therapeutics on intracellular mycobacterial load was also assessed. Results. Macrophages infected with intracellular mycobacteria phenocopied NPC cells, exhibiting accumulation of multiple lipid types, reduced lysosomal Ca (2+ )levels, and defects in intracellular trafficking. These NPC phenotypes could also be induced using only lipids/glycomycolates from the mycobacterial cell wall. These data suggest that intracellular mycobacteria inhibit the NPC pathway, likely via inhibition of the NPC1 protein, and subsequently induce altered acidic store Ca (2+) homeostasis. Reduced lysosomal calcium levels may provide a mechanistic explanation for the reduced levels of phagosome-lysosome fusion in mycobacterial infection. Treatments capable of correcting defects in NPC mutant cells via modulation of host cell calcium were of benefit in promoting clearance of mycobacteria from infected host cells. Conclusion. These findings provide a novel mechanistic explanation for mycobacterial intracellular persistence, and suggest that targeting interactions between the mycobacteria and host cell pathways may provide a novel avenue for development of anti-TB therapies. F1000Research 2017-06-21 /pmc/articles/PMC5172425/ /pubmed/28008422 http://dx.doi.org/10.12688/wellcomeopenres.10036.2 Text en Copyright: © 2017 Fineran P et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Fineran, Paul Lloyd-Evans, Emyr Lack, Nathan A. Platt, Nick Davis, Lianne C. Morgan, Anthony J. Höglinger, Doris Tatituri, Raju Venkata V. Clark, Simon Williams, Ian M. Tynan, Patricia Al Eisa, Nada Nazarova, Evgeniya Williams, Ann Galione, Antony Ory, Daniel S. Besra, Gurdyal S. Russell, David G. Brenner, Michael B. Sim, Edith Platt, Frances M. Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway |
title | Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway |
title_full | Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway |
title_fullStr | Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway |
title_full_unstemmed | Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway |
title_short | Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway |
title_sort | pathogenic mycobacteria achieve cellular persistence by inhibiting the niemann-pick type c disease cellular pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172425/ https://www.ncbi.nlm.nih.gov/pubmed/28008422 http://dx.doi.org/10.12688/wellcomeopenres.10036.2 |
work_keys_str_mv | AT fineranpaul pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT lloydevansemyr pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT lacknathana pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT plattnick pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT davisliannec pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT morgananthonyj pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT hoglingerdoris pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT tatiturirajuvenkatav pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT clarksimon pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT williamsianm pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT tynanpatricia pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT aleisanada pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT nazarovaevgeniya pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT williamsann pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT galioneantony pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT orydaniels pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT besragurdyals pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT russelldavidg pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT brennermichaelb pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT simedith pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway AT plattfrancesm pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway |